The present systematic review suggested that among kidney transplant recipients, mild gastrointestinal adverse effects, such as nausea and vomiting, were the most common complications of GLP1-RA therapy, while only one case (0.4%) of pancreatitis has been reported. This evidence concerns the gene GLP1R and pancreatitis.